Improving the Detection and Management of Kidney Health in Primary Care

Author:

Robson Breonny1ORCID,Deed Gary23,Phoon Richard KS45

Affiliation:

1. Kidney Health Australia, Melbourne, Victoria, Australia

2. Healthcare Plus Medical Centre, Coorparoo, Queensland, Australia

3. Monash University, Melbourne, Victoria, Australia

4. Department of Renal Medicine, Centre for Transplant and Renal Research, Westmead Hospital, Westmead, Australia

5. Faculty of Medicine and Health, The University of Sydney, Sydney, Australia

Abstract

Chronic kidney disease (CKD) is a major cause of morbidity and mortality, contributing to approximately 20 000 deaths in 2021 in Australia. Importantly, progression of CKD can be substantially reduced if it is detected and treated early. Here we present the perspectives of a general practitioner (primary care physician), a nephrologist and a patient advocate on how the diagnosis and management of CKD in primary care could be improved. Early detection and treatment of CKD are impeded by limited patient awareness and knowledge, communication challenges between patients and doctors, and psychosocial issues, with these factors also interacting with, and exacerbating, each other. We make the following recommendations to help improve outcomes in patients with CKD: (1) identifying people at increased risk of CKD and ensuring they have a complete kidney health check (including estimated glomerular filtration rate, urine albumin-creatinine ratio and a blood pressure check) every 1−2 years; (2) using simple, nonconfrontational language and supportive resources to communicate with patients about kidney health; (3) implementing early treatment to slow the progression of CKD and avoid adverse cardiovascular disease outcomes; and (4) asking patient-orientated questions to support shared decision-making and empower patients to be active partners in their healthcare. We acknowledge that limited time is a major barrier to implementing these recommendations in primary care. Utilizing the expertise of the whole practice team, and adopting supportive technology to introduce efficiencies, are likely to be of benefit. By adopting these recommendations, we believe general practitioners have the opportunity to drive improved outcomes and quality of life for people living with CKD in Australia.

Funder

AstraZeneca Australia

Publisher

SAGE Publications

Reference16 articles.

1. Australian Institute of Health and Welfare. Chronic kidney disease: Australian facts. 2023; Accessed May 14, 2024. https://www.aihw.gov.au/reports/chronic-kidney-disease/chronic-kidney-disease/contents/about.

2. The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

3. Deloitte Access Economics. Changing the chronic kidney disease landscape: the economic benefits of early detection and treatment. Melbourne, Vic: Report commissioned by Kidney Health Australia; 2023. Accessed December 8, 2023. https://www2.deloitte.com/content/dam/Deloitte/au/Documents/Economics/deloitte-au-economics-kidney-health-australia-report-80323.pdf.

4. Knowledge deficit of patients with stage 1-4 CKD: A focus group study

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3